| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ENZALUTAMIDE (has an active metabolite)
| ENZALUTAMIDE | ANTINEOPLASTIC | ORAL | Cmax 35.7 MICROMOLAR Tmax 1 HOUR VD 110 LITER PPB 97 PERCENT Cl 0.56 LITER / HOUR HT 139 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | ANDROGEN RECEPTOR (AR) | Androgen receptor UNIPROT P10275 AR more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M ENZALUTAMIDE (is an active metabolite)
| ENZALUTAMIDE | ANTINEOPLASTIC | - | Cmax 28.2 MICROMOLAR VD 288 LITER (EQN) PPB 95 PERCENT Cl 1.02 LITER / HOUR HT 196 HOUR | ANDROGEN RECEPTOR (AR) | Androgen receptor UNIPROT P10275 AR more at DrugCentral | EMA | |||
